SCHEMBL7428137

SCHEMBL7428137

CCn1ncc2c(Cl)c3ccc(C)cc3nc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 5/20 0.46
PGR P06401 1/20 0.46
PDE4B Q07343 1/20 0.46
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
PDE10A Q9Y233 1/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 3/20 0.38
TSHR P16473 2/20 0.38
MAPT P10636 2/20 0.38
RECQL P46063 1/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
HSD17B10 Q99714 3/20 0.38
GAA P10253 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.36
HPGD P15428 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7338680 0.83 PDE1A (0.44) PDE4BKMT2AMEN1ADORA3ADORA2A
SCHEMBL7332532 0.81 MAOA (0.50) NR3C1KMT2AMEN1ADORA3ADORA2A
SCHEMBL7338172 0.81 HCAR3 (0.46) NR3C1PGRPDE4BKMT2AMEN1
SCHEMBL7330355 0.80 LMNA (0.41) KMT2AMEN1ADORA2AADORA1MAPT
SCHEMBL7338059 0.77 PDE10A (0.56) KMT2AMEN1PDE10ANPSR1TSHR
SCHEMBL7328414 0.77 RXFP1 (0.50) NR3C1PGRPDE4BADORA3ADORA2A
SCHEMBL7330632 0.75 PDE1A (0.44) PDE4BKMT2AMEN1PDE10ANPSR1
SCHEMBL7328438 0.75 PIM1 (0.43) NR3C1PGRPDE4BADORA3ADORA2A
SCHEMBL9595057 0.75 NQO2 (0.50) KMT2ANPSR1MAPTALDH1A1KDM4E
SCHEMBL7419604 0.74 ACHE (0.53) NR3C1PDE4BKMT2AMEN1ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6008226-A AN ENZYME INHIBITOR OF C-GMP-PHOSPHODIESTERASE FOR TREATING HEART FAILURE, HYPERTENSION, REVERSING OR REDUCING NITRATE-INDUCED TOLERANCE AND ANGINA PECTORIS, CONGESTIVE HEART DISEASE AND MYOCARDIAL INFARCTION SANOFI-SYNTHELABO (FR) 1999-12-28 US disclosed
US-5852035-A Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines CELL PATHWAYS, INC. (US) 1998-12-22 US disclosed
US-5843956-A Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4-b) quinolin-4-amines and compositions and methods of use thereof SANOFI (FR) 1998-12-01 US disclosed
US-5614530-A GMP PHOSPHODIESTERASE INHIBITOR, HYPOTENSIVE STERLING WINTHROP INC. (US) 1997-03-25 US disclosed
WO-1996028159-A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-09-19 WO disclosed